Compounds > 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole

9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole and Epilepsy

9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole has been researched along with Epilepsy* in 1 studies

Other Studies

1 other study(ies) available for 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole and Epilepsy

ArticleYear
GABAergic Mechanism of Anticonvulsive Effect of Chemical Agent RU-1205.
    Bulletin of experimental biology and medicine, 2018, Volume: 164, Issue:5

    The study examined the effect of 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo[1,2-α] benzimidazole dihydrochloride (RU-1205) on the latency of seizures provoked by corazol, bicuculline, or picrotoxin. This agent (10 and 20 mg/kg) increased the seizure latency in the experimental models of epileptogenesis. The blockers of GABA

    Topics: Animals; Anticonvulsants; Benzimidazoles; Brain; Epilepsy; Mice; Morpholines; Picrotoxin; Rats; Receptors, GABA-A

2018